Foetal and adult human CYP3A isoforms in the bioactivation of organophosphorothionate insecticides

Toxicology Letters

Volumn 167, Issue 3, 2006, Pages 245-255

  Buratti, Franca M ^a   Leoni, Claudia ^a   Testai, Emanuela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

CYP3A4; CYP3A5; CYP3A7; Foetal metabolism; Organophosphorothionate pesticides

Indexed keywords

CHLORPYRIFOS; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; CYTOCHROME P450 3A5; CYTOCHROME P450 3A7; FENTHION; MALATHION; ORGANOPHOSPHATE INSECTICIDE; PARATHION; PHOSPHORODITHIOIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME MECHANISM; FETUS; FETUS LIVER; HUMAN; LIVER CLEARANCE; LIVER MICROSOME METABOLISM; MOUSE; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN VARIANT; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FETUS; INSECTICIDES; ISOENZYMES; ORGANOTHIOPHOSPHORUS COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33751184937     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.10.006     Document Type: Article

References (45)

1. 14C]chlorpyrifos in pregnant rats. Arch. Toxicol. 76 (2002) 452-459
2. Adgate J.L., Barr D.B., Clayton C.A., Eberly L.E., Freeman N.C.G., Lioy P.J., Needham L.L., Pellizzari E.D., Quackenboss J.J., Roy A., and Sexton K. Measurement of children's exposure to pesticides: analysis of urinary metabolite levels in a probability-based sample. Environ. Health Perspect. 109 (2001) 583-589
3. Aldridge J.E., Levin E.D., Seidler F.J., and Slotkin T.A. Developmental exposure of rats to chlorpyrifos leads to behavioral alterations in adulthood, involving serotonergic mechanisms and resembling animal models of depression. Environ. Health Perspect. 113 (2005) 527-531
4. Berkowitz G.S., Wetmure J.G., Birman-Deych E., Obel J., Lapinsky R.H., Godbold J.H., Holzman I.R., and Wolff M.S. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ. Health Perspect. 112 (2004) 388-391
5. Buratti F.M., D'Aniello A., Volpe M.T., Meneguz A., and Testai E. Malathion bioactivation in the human liver: the contribution of different cytochrome P450 isoforms. Drug Metab. Dispos. 33 (2005) 295-302
6. Buratti F.M., Volpe M.T., Fabrizi L., Meneguz A., Vittozzi L., and Testai E. Kinetic parameters of OPT pesticide desulfuration by c-DNA expressed human CYPs. Environ. Toxicol. Pharmacol. 11 (2002) 181-190
7. Buratti F.M., Volpe M.T., Meneguz A., Vittozzi L., and Testai E. CYP-specific bioactivation of four organophosphorothionate pesticides by human liver microsomes. Toxicol. Appl. Pharmacol. 186 (2003) 143-154
8. Burk O., Tegude H., Koch I., Hustert E., Wolbold R., Glaeser H., Klein K., Fromm M.F., Nuessler A.K., Neuhaus P., Zanger U.M., Eichelbaum M., and Wojnowski L. Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestine. J. Biol. Chem. 277 (2002) 24280-24288
9. Costa L.G., Vitalone A., Cole T.B., and Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69 (2005) 541-550
10. Cresteil T. Onset of xenobiotic metabolism in children: toxicological implications. Food Add. Contamin. 15 (1998) 45-51
11. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. Quart. J. Med. 93 (2000) 715-731
12. Eddleston M., and Phillips M.R. Self-poisoning with pesticides. Brit. Med. J. 328 (2004) 42-44
13. Ellman G.L., Courtney D.K., Andres Jr. V., and Featherstone R.M. A new rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
14. Eskenazi B., Harley K., Bradman A., Weltzien E., Jewell N.P., Barr D.B., Furlong C.E., and Holland N.T. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in a agricultural population. Environ. Health Perspect. 112 (2004) 1116-1124
15. Fenske R.A., Kedan G., Lu C., Fisker-Andersen J.A., and Curl C.L. Assessment of organophosphorus pesticide exposure in the diets of preschool children in Washington State. J. Expos. Anal. Environ. Epidemiol. 12 (2002) 21-28
16. Fenske R.A., Kissel J.C., Lu C., Kalman D.A., Simcox N.J., Allen E.H., and Keifer M.C. Biologically based pesticide dose estimates for children in an agricultural community. Environ. Health Perspect. 108 (2000) 515-520
17. Forsyth C.S., and Chambers J.E. Activation and degradation of the phosphorothionate insecticides parathion and EPN by rat brain. Biochem. Pharmacol. 38 (1989) 1597-1603
18. Hakkola J., Pelkonen O., Pasanen M., and Raunio H. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit. Rev. Toxicol. 28 (1998) 35-72
19. Huang W., Lin Y.S., McConn II D.J., Calamia J.C., Totah R.A., Isoherranen N., Glodowski M., and Thummel K.E. Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. Drug Metab. Dispos. 32 (2004) 1434-1445
20. Jamal G.A., Hansen S., and Julu P.O.O. Low level exposures to organophosphorus esters may cause neurotoxicity. Toxicology 181-182 (2002) 23-33
21. Krieger R.I., and Dinoff T.M. Malathion deposition, metabolite clearance, and cholinesterase status of date dusters and harvesters in California. Arch. Environ. Contam. Toxicol. 38 (1999) 546-553
22. Kuehl P., Zhang J., Lin Y., Lamba J., Assem M., Schuetz J., Watkins P.B., Daly A., Wrighton S.A., and Hall S.D. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet. 27 (2001) 383-391
23. Kutz F., Cook B.T., Carter-Pokras O.D., Brody D., and Murphy R.S. Selected pesticide residues and metabolites in urine from a survey of the US general population. J. Toxicol. Environ. Health 37 (1992) 277-291
24. Leoni C., Buratti F.M., and Testai E. Fenthion bioactivation by recombinant human CYPs and FMO. Drug Metab. Rev. 38 Suppl. 1 (2006) 100-101
25. Lin Y.S., Dowling A.L., Quigley S.D., Farin F.M., Zhang J., Lamba J., Schuetz E.G., and Thummel K.E. Co-regulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism. Mol. Pharmacol. 62 (2002) 162-172
26. Meneguz A., Bisso G.M., and Michalek H. Alterations in the distribution of cholinesterase molecular forms in maternal and fetal brain following diisopropyl fluorophosphate treatment of pregnant rats. Neurochem. Res. 14 (1989) 285-291
27. Needham L.L. Assessing exposure to organophosphorus pesticides by biomonitoring in epidemiologic studies of birth outcomes. Environ. Health Perspect. 113 (2005) 494-498
28. Nolan R.J., Rick D.L., Freshour N.L., and Saunders J.H. Chlorpyrifos: pharmacokinetics in human volunteers. Toxicol. Appl. Pharmacol. 73 (1984) 8-15
29. Pelkonen O. Biotransformation of xenobiotics in the fetus. Pharmac. Ther. 10 (1980) 261-281
30. Ricceri, L., Venerosi, A., Capone, F., Cometa, M.F., Lorenzini, P., Fortuna, S., Calamandrei, G., 2006. Developmental neurotoxicity of organophosphorous pesticides: fetal and neonatal exposure to chlorpyrifos alters sex-specific behaviors at adulthood in mice. Toxicol. Sci. (on line).
31. Rigas M.L., Okino M.S., and Quackenboss J.J. Use of pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurement. Toxicol. Sci. 61 (2001) 374-381
32. Schuetz J.D., Beach D.L., and Guzelian P.S. Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver. Pharmacogenetics 4 (1994) 11-20
33. Schuetz J.D., Kauma S., and Guzelian P.S. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. J. Clin. Invest. 92 (1993) 1018-1024
34. Schurdut B.A., Barraj L., and Francis M. Aggregate exposures under the food quality protection act: an approach using chlorpyrifos. Regul. Toxicol. Pharmacol. 28 (1998) 165-177
35. Stevens J.C., Hines R.N., Gu C., Koukouritaki S.B., Manro J.R., Tandler P.J., and Zaya M.J. Developmental expression of the major human hepatic CYP3A enzymes. J. Pharmacol. Exp. Therap. 307 (2003) 573-582
36. Sultatos L.G. Mammalian toxicology of organophosphorus pesticides. J. Toxicol. Environ. Health 43 (1994) 271-289
37. Tang J., Cao Y., Rose R.L., Brimfield A.A., Dai D., Goldstein J.A., and Hodgson E. Metabolism of chlorpyrifos by human cytochrome P450 isoforms and human, mouse, and rat liver microsomes. Drug Metab. Disp. 29 (2001) 1201-1204
38. Vittozzi L., Fabrizi L., Di Consiglio E., and Testai E. Mechanistic aspects of organophosphorothionate toxicity in fish and mammals. Environ. Int. 26 (2001) 125-129
39. Westlind-Johnsson A., Malmebo S., Johansson A., Otter C., Andersson T.B., Johansson I., Edwards R.J., Boobis A.R., and Ingelman-Sundberg M. Comparative analysis of CYP3A expression in human liver suggest only a minor role for CYP3A5 in drug metabolism. Drug Metab. Dispos. 31 (2003) 755-761
40. Whyatt R.M., and Barr D.B. Measurement of organophosphate metabolites in postpartum meconium as potential biomarker of prenatal exposure: a validation study. Environ. Health Perspect. 109 (2001) 417-420
41. Whyatt R.M., Rauh V., Barr D.B., Camann D.E., Andrews H.F., Garfinkel R., Hoepner L.A., Diaz D., Dietrich J., Reyes A., Tang D., Kinney P.L., and Perera F.P. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ. Health Perspect. 112 (2004) 1125-1132
42. Williams J.A., Ring B.J., Cantrell V.E., Jones D.R., Eckstein J., Ruterbories K., Hamman M.A., Hall S.D., and Wrighton S.A. Comparative metabolic capabilities of CYP3A4, CYP3A5 and CYP3A7. Drug Metab. Dispos. 30 (2002) 883-891
43. Wrighton S.A., Brian W.R., Sari M.-A., Iwasaki M., Guengerich F.P., Raucy J.L., Molowa D.T., and VandenBranden M. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol. Pharmacol. 38 (1990) 207-213
44. Wrighton S.A., and VandenBranden M. Isolation and characterization of human fetal liver cytochrome P450HLp2: a third member of the P450III gene family. Arch. Biochem. Biophys. 268 (1989) 144-151
45. Yasmashita M., Tanaka J., and Ando Y. Human mortality in organophosphate poisoning. Vet. Hum. Toxicol. 39 (1997) 84-85